Literature DB >> 22424020

Immediate and late outcome of patients aged 80 years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies.

Francesco Vasques1, Andrea Messori, Ersilia Lucenteforte, Fausto Biancari.   

Abstract

OBJECTIVE: This study was planned to evaluate the outcome of patients ≥80 years old undergoing isolated conventional aortic valve replacement (AVR).
METHODS: Systematic review of the literature and meta-analysis of data on octogenarians and nonagenarians who underwent isolated AVR were performed.
RESULTS: The literature search yielded 48 observational studies reporting on 13 216 patients ≥80 years old. Pooled proportion of immediate postoperative mortality was 6.7 % (95% CI 5.8-7.5, 47 studies, 13,092 patients), and it was 5.8% (95% CI 4.8-6.9) in 18 studies with a mid-date from 2000 to 2006 and 7.5% (95% CI 6.8-8.2) in 30 studies with a mid-date from 1982 to 1999 (P = .004). Pooled proportion of postoperative stroke was 2.4% (95% CI 2.1-2.7, 21 studies, 8,436 patients), that of postoperative dialysis was 2.6% (95% CI 1.6-3.8, 10 studies, 1,945 patients), and that of postoperative implantation of a pacemaker was 4.6% (95% CI 3.6-5.8, 6 studies, 1,470 patients). Pooled survival rates at 1, 3, 5, and 10 years after isolated AVR were 87.6%, 78.7%, 65.4%, and 29.7%, respectively.
CONCLUSIONS: Immediate postoperative mortality and morbidity after isolated AVR in patients ≥80 years old are rather low. Postoperatively mortality decreased even further in the most recent series. Importantly, isolated AVR in these high-risk patients was associated with good late survival. These findings suggest that advanced age alone cannot be considered as a contraindication to conventional isolated AVR and that any new valve prosthesis implanted in these patients should be durable enough to guarantee the results so far offered by conventional surgery. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424020     DOI: 10.1016/j.ahj.2011.12.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  24 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  The learning curve associated with transapical aortic valve implantation.

Authors:  Jörg Kempfert; Ardawan Rastan; David Holzhey; Axel Linke; Gerhard Schuler; Friedrich Wilhelm Mohr; Thomas Walther
Journal:  Ann Cardiothorac Surg       Date:  2012-07

3.  Learning experience with transapical aortic valve implantation - the initial series from Leipzig.

Authors:  Jörg Kempfert; Thomas Walther
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

4.  Biologic agents in rheumatoid arthritis: temporal trend of incremental benefits.

Authors:  Andrea Messori; Dario Maratea; Valeria Fadda; Sabrina Trippoli
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-12       Impact factor: 5.346

5.  [Transcutaneous aortic valve implantation].

Authors:  H Möllmann; C Liebetrau; H Nef; J Kempfert; T Walther; C Hamm
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

6.  Temporal trend of overall survival in patients with advanced non-small cell lung cancer given first-line cytotoxic treatments.

Authors:  Andrea Messori; Dario Maratea; Valeria Fadda; Sabrina Trippoli
Journal:  Lung       Date:  2012-10-19       Impact factor: 2.584

7.  Aortic stenosis in high-risk patients. Surgical therapy.

Authors:  T Walther; M Arsalan; J Blumenstein; A van Linden; J Kempfert
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

8.  Cardiac surgery in nonagenarians: not only feasible, but also reasonable?

Authors:  Alexander Assmann; Jan-Philipp Minol; Arash Mehdiani; Payam Akhyari; Udo Boeken; Artur Lichtenberg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04-28

Review 9.  Contemporary strategy for aortic valve stenosis in octogenarians.

Authors:  Hiroyuki Tsukui; Kenji Yamazaki
Journal:  Surg Today       Date:  2013-07-14       Impact factor: 2.549

Review 10.  Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations.

Authors:  Michael N Young; Ignacio Inglessis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.